By learning from real-world experiences, we continue to refine our solutions and drive change
Take it at the wrong time and you're still getting benefits, but you're leaving some on the table
Two-year sustained weight loss and metabolic benefits with controlled release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Weight loss rates on Retatrutide vary significantly based on starting weight, age, sex, metabolic rate, adherence level, and factors we do not fully understand yet
A treatment that reflects the true complexity of weight biology, not the old story that success depends on willpower alone
When medication changes your patterns, your brain might still crave food in the amounts and at the times it's used to